BioCentury
ARTICLE | Financial News

5AM incubator spinout Homology raises $43.5M

May 3, 2016 1:35 AM UTC

Gene editing company Homology Medicines Inc. spun out of 5AM Ventures' incubator with a $43.5 million series A round led by 5AM and Arch Venture Partners. Temasek, Deerfield and Arch Overage Fund also participated.

Homology's platform uses adeno-associated viral (AAV) vectors derived from CD34+ hematopoietic stem cells (HSCs) to induce gene editing through homologous recombination. The newco plans to use the platform for therapeutic in vivo gene editing, with an initial focus on rare monogenic diseases including hemoglobinopathies, inborn errors of metabolism and CNS disorders (see BioCentury, May 2). ...